Epidemiología y nuevos métodos de estimación del riesgo, en casos de pandemias: COVID-19
Epidemiology and new methods of risk estimation in pandemic cases: COVID-19
DOI:
https://doi.org/10.15446/rsap.v23n3.89753Palabras clave:
Coronavirus, infecciones, neumonía, salud pública, tratamiento (es)Coronavirus, infections, pneumonia, public healt, therapeutics (en)
Descargas
Durante el periodo de la pandemia por la COVID-19 se han realizado importantes intervenciones conductuales, clínicas y estatales en busca de mitigar y prevenir la persistencia del virus en la población humana. No obstante, aún no existe claridad de cómo estas intervenciones sin precedentes, incluidas las restricciones de viaje, afectaron la propagación de la COVID-19 en China y en otros países. Por ello, el objetivo de la presente investigación fue describir las principales características epidemiológicas de la COVID-19, a través del análisis de las principales medidas establecidas. Se utilizaron datos de 40 artículos científicos referentes a la pandemia y al virus, considerando información de relevancia respecto a este, como su comportamiento, sintomatología, epidemiología, tratamiento y métodos de mitigación a nivel mundial, así como un plan de medidas de control que se propuso en Perú para mitigar la propagación comunitaria de la enfermedad por coronavirus 2019 y poder estar preparado para futuras enfermedades de igual o mayor proporción que la actual.
During the COVID-19 pandemic, there have been important behavioral, clinical and government interventions to mitigate and prevent the spread of the virus in the population. However, there is no evidence of how these interventions, including the travel restrictions, affect the spread of COVID-19 in China and other countries. The objective of this research is to describe the main epidemiological characteristics of COVID-19 through the analysis of the main measures established. The sample included 40 scientific articles related to the pandemic and virus, considering relevant information regarding the behavior, symptomatology, epidemiology, treatment and methods of mitigation globally as well as a plan of control measures proposed in Peru to mitigate the spread of COVID-19 and to be prepared for future pandemics.
Referencias
Masters PS. Coronavirus genomic RNA packaging. Virology. 2019; 537:198- 207. https://doi.org/10.1016/j.virol.2019.08.031.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. 2020; 8(4):420-2. http://dx.doi.org/10.1016/S2213-2600(20)30076-X.
Sun J, He W, Wang L, Lai A, Ji X, Zhai X, et al. COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med. 2020; 1-13. https://doi.org/10.1016/j.molmed.2020.02.008.
Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect. 2020; 35:100679. https://doi.org/10.1016/j.nmni.2020.100679
Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA [Internet]. 2020 [cited 2020 Apr 23]; 323(14):1406-7. https://doi.org/10.1001/jama.2020.2565.
Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-4. http://dx.doi.org/10.1016/S0140-6736(20)30628-0.
Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 — Studies Needed. N Engl J Med. 2020; 382(13):1194-6. https://doi.org/10.1056/NEJMp2002125.
Cowling BJ, Leung GM. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Euro surveill. 2020; 25(6):1-5. https://dx.doi.org/10.2807%2F1560-7917.ES.2020.25.6.2000110.
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395(10231):1225-8. http://dx.doi.org/10.1016/S0140-6736(20)30627-9.
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report–72 [Internet]. Geneva: WHO;2020 Apr [cited 2020 Apr 23]. https://bit.ly/3Ayx8pF.
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020; 14(1):72-3. https://doi.org/10.5582/bst.2020.01047.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [cited Apr 23]; 395(10223):507-13. http://dx.doi.org/10.1016/S0140-6736(20)30211-7.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109(102433):1-4. https://doi.org/10.1016/j.jaut.2020.102433.
Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. J Clin Med. 2020; 9(4):967. https://doi.org/10.3390/jcm9040967.
León-Castellón R, Bender del Busto J, Velázquez-Pérez L. Ciencias biomédicas. Afectación del sistema nervioso por la COVID-19. An la Acad ciencias Cuba [Internet]. 2020 [cited 2020 Apr 23];10(2). https://bityl.co/AenB.
Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Heal [Internet]. 2020 [cited 2020 Mar 25]; 25(3):278-80. https://doi.org/10.1111/tmi.13383.
Reina J, López-Causapé C, Rojo-Molinero E, Rubio R. Características de las infecciones respiratorias agudas causadas por los coronavirus OC43, NL63 y 229E. Rev Clínica Española [Internet]. 2014; 214(9):499-504. http://dx.doi.org/10.1016/j.rce.2014.05.020.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13. http://dx.doi.org/10.1016/S0140-6736(20)30211-7.
Cowling BJ, Leung GM. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Euro surveill. 2020; 25(6):1-5. https://dx.doi.org/10.2807%2F15607917.ES.2020.25.6.2000110.
Guan W, Ni Z, Hu Y, Liang W-H, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 1-13. https://dx.doi.org/10.1016%2Fj.jemermed.2020.04.004.
De Campos Tuñas I, Da Silva E, Santoro S, Maia K, Silva-Júnior G. Doença pelo Coronavírus 2019 (COVID-19): Uma abordagem preventiva para Odontologia. Rev Bras Odontol [Internet]. 2020 [cited 2020 Mar 24]; 77:1-7. https://bityl.co/AenW.
Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, una emergencia de salud pública mundial. Rev Clínica Española. 2020; 1-7. https://doi.org/10.1016/j.rce.2020.03.001.
Bukhari Q, Jameel Y. Will Coronavirus Pandemic Diminish by Summer? SSRN Electron J [Internet]. 2020; 1-15. https://dx.doi.org/10.2139/ssrn.3556998.
Rodríguez-Morales AJ, Sánchez-Duque JA, Hernández Botero S, Pérez-Díaz CE, Villamil-Gómez WE, Méndez CA, et al. Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina. Acta Médica Perú. 2020; 37(1):3-7. http://dx.doi.org/10.35663/amp.2020.371.909.
Jung S, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. J Clin Med. 2020; 9(2):523. https://doi.org/10.3390/jcm9020523.
Bayes C, Rosas VS, Valdivieso L. Modelling death rates due to COVID-19: A Bayesian approach. arXiv [Internet]. 2020 [cited 2020 Mar 25]; 1-10. http://arxiv.org/abs/2004.02386.
Luque N, Salcedo C. COVID-19 y las unidades de cuidados intensivos en el Perú. Rev Med Intensiva y Cuid Críticos [Internet]. 2020 [cited 2020 Apr 25]; 13(1):40-4. https://bityl.co/Aenm.
Gozzer E, Canchihuamán F, Espiniza R. COVID-19 y la necesidad de actuar. Rev Peru Med Exp Salud Pública. 2020; 37(2). https://doi.org/10.17843/rpmesp.2020.372.5410.
Torres-Roman JS, Kobiak IC, Valcarcel B, Diaz-Velez C, La Vecchia C. The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes. Travel Med Infect Dis. 2020; 101689. https://doi.org/10.1016/j.tmaid.2020.101689.
Maguiña Vargas C. Reflexiones sobre el COVID-19, el Colegio Médico del Perú y la Salud Pública. Acta méd Peru. 2020; 37(1):19-21. http://dx.doi.org/10.35663/amp.2020.371.929.
Escobar G, Matta J, Taype-Huamaní W, Ayala R, Amado J. Características clínico-epidemiológicas de pacientes fallecidos por COVID-19 en un hospital nacional de Lima, Perú. Rev la Fac Med Humana. 2020; 20(2):180-5. https://doi.org/10.25176/RFMH.v20i2.2940.
Otoya-tono AM, García M, Jaramillo-Moncayo C, Wills C. COVID-19: generalidades, comportamiento epidemiológico y medidas adoptadas en medio de la pandemia en Colombia. Acta de Otorrinolaringología y Cirugía de Cabeza y Cuello. 2020; 4-13. https://doi.org/10.37076/acorl.v48i1.519.
Ramses Salas-Asencios, Iannacone-Oliver J, Guillén-Oneeglio A, Fieno JT-D, Alvariño-Flores L, Castañeda-Pérez L, et al. Coronavirus Covid-19: Knowing the Cause of the Pandemic. Biol. 2020; 18(1):9-27. http://dx.doi.org/10.24039/rtb2020181442.
Ebrahim SH, Ahmed QA, Gozzer E, Schlagenhauf P, Memish ZA. COVID-19 and community mitigation strategies in a pandemic. BMJ. 2020; 368:1066. http://dx.doi.org/doi:10.1136/bmj.m1066.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; 104(3):246-51. https://doi.org/10.1016/j.jhin.2020.01.022.
Wong T-W, Tam WW-S. Handwashing practice and the use of personal protective equipment among medical students after the SARS epidemic in Hong Kong. Am J Infect Control. 2005; 33(10):580-6. https://doi.org/10.1016/j.ajic.2005.05.025.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020; 395(10228):931-4. https://doi.org/10.1016/S0140-6736(20)30567-5.
Nacoti M, Ciocca A, Giupponi A, Brambillasca P, Lussana F, Pisano M, et al. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: Changing perspectives on preparation and mitigation. NEJM Catal Innov Care Deliv [Internet]. 2020 [cited 2020 Mar 25];1-5. https://bityl.co/AfdT.
Manrique-Abril, Fred G, et al. Modelo SIR de la pandemia de COVID-19 en Colombia. Rev. Salud Pública (Bogotá). 2020; 22(2):1-9. https://doi.org/10.15446/rsap.v22.85977.
Wang G, Zhang Y, Zhao J, Zhang J, Jiang F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. Lancet. 2020; 395(10228):945-7. https://doi.org/10.1016/S0140-6736(20)30547-X.
Parodi SM, Liu VX. From containment to mitigation of COVID-19 in the US. JAMA. 2020; 323(15):1441-2. https://doi.org/10.1001/jama.2020.3882.
Batista M. Estimation of the final size of the second phase of coronavirus epidemic by the logistic model. MedRxiv. 2020. https://doi.org/10.1101/2020.03.11.20024901.
World Health Organization. COVID-19 Situation [Internet]. Geneva: WHO; 2020 [cited 2020 Mar 26]. https://bit.ly/39un8i3.
Jia W, Han K, Song Y, Cao W, Wang S, Yang S, et al. Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China. MedRxiv. 2020. https://doi.org/10.3389/fmed.2020.00169.
Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand [Internet]. London: Imperial College COVID-19 Response Team; 2020 [cited 2020 Apr 26]. https://bit.ly/2vZooMl.
Vernon V, Calvin J, Chiew C, et al. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020; 27(3): taaa039. https://doi.org/10.1093/jtm/taaa039.
Zhu ZB, Zhong CK, Zhang KX, et al. [Epidemic trend of corona virus disease 2019 (COVID-19) in Chinese mainland]. Chinese Journal of Preventive Medicine. 2020 Jun 6; 54(6):620-4. https://doi.org/10.3760/cma.j.cn112150-20200222-00163.
Wu JT, Leung K, Bushman M, Kishore N, Niehus R, De Salazar P, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020; 26(4):506-510. https://doi.org/10.1038/s41591-020-0822-7.
Surveillances, Vital. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China. China CDC Weekly. 2020; 2(8)113-22. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003.
Giuliani D, Dickson MM, Espa G, Santi F. Modelling and predicting the spatio-temporal spread of Coronavirus disease 2019 (COVID-19) in Italy. 2020 [cited 2020 Mar 26]; https://doi.org/10.48550/arXiv.2003.06664.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2021 Revista de Salud Pública

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al publico apoya a un mayor intercambio de conocimiento global.
Todos los contenidos de esta revista, excepto dónde está identificado, están publicados bajo una Licencia Creative Commons Atribución 4.0.